MTM Laboratories

Paired with Roche's HPV testing offerings, the deal will expand its cervical cancer testing capabilities.

The German-based company expects to file its test for FFPE within the next few months, and to start a clinical trial for its cytology test by mid-year.

The funds will be used to support clinical trials and commercialization efforts, as well as US regulatory clinical trials for a PMA submission for its CINtec Plus Cytology platform.

The CTAF recommendation is "an important decision-making resource for clinicians and patients," the firm's CEO said.

Patents awarded to GeneNews, US Army, Aisin Seiki, MTM Laboratories, and USC.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.